Join
Live feed
·
INSIDERFilingvia Quantisnow
Maze Therapeutics Inc. logo

Large owner Third Rock Ventures Iv, L.P. converted options into 6,713,588 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MAZE· Maze Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MAZE (Maze Therapeutics Inc.) and more on Quantisnow.